Quest Diagnostics (DGX) Tops Q2 EPS by 5c, Revenues Beat; Offers FY19 EPS/Revenue Guidance
Tweet Send to a Friend
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.73, $0.05 better than the analyst estimate of $1.68. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
